By Mill Chart
Last update: Jul 21, 2025
CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) stands out as an affordable growth stock based on our screening criteria. The company combines strong growth metrics with solid profitability and financial health, all while maintaining a reasonable valuation. Here’s why CPRX fits the profile of a promising investment opportunity.
CPRX has demonstrated impressive growth, with key highlights including:
These figures place CPRX in the top tier of growth stocks within the biotechnology sector.
Despite its strong growth, CPRX remains attractively priced:
The stock’s low PEG ratio further supports the case that its valuation compensates well for its growth trajectory.
CPRX excels in profitability and financial stability:
These factors make CPRX a low-risk choice within the growth stock category.
For a deeper look at CPRX’s fundamentals, review the full fundamental analysis report.
Our Affordable Growth screener lists more stocks with similar characteristics and is updated daily.
This is not investing advice! The article highlights observations at the time of writing, but you should conduct your own analysis before making investment decisions.
NASDAQ:CPRX (7/23/2025, 9:51:05 AM)
21.02
+0.12 (+0.57%)
Find more stocks in the Stock Screener